Complications in Radical Prostatectomy: Links to Recurrence and Mortality
Overview
This study from the LAPPRO trial investigated the association between intraoperative adverse events during radical prostatectomy and long-term oncological outcomes. Findings indicate that adverse events during surgery are linked to higher rates of cancer recurrence and mortality over 12 years, with differences observed between open and robot-assisted approaches.
Background
Prostate cancer is the most common cancer in Sweden, with treatment options including radiotherapy and radical prostatectomy. Radical prostatectomy can be performed via open surgery (ORP) or robot-assisted laparoscopic prostatectomy (RALP), with RALP increasingly favored for its minimally invasive nature. The LAPPRO trial compared these techniques, focusing on functional outcomes and long-term cancer-specific mortality. Adverse intraoperative events may impact surgical radicality and immune response, potentially influencing recurrence and survival.
Data Highlights
Adverse Event Category
Definition
Threshold ORP
Threshold RALP
Prolonged Operating Time
Longest 10% of operation duration
>171.2 minutes
>264 minutes
Extensive Perioperative Bleeding
Highest 10% of bleeding volume
>1300 ml
>400 ml
Key Findings
Adverse events during radical prostatectomy were associated with increased risk of prostate cancer recurrence within 12 years post-surgery.
Patients experiencing intraoperative complications had higher prostate cancer-specific and all-cause mortality compared to those without adverse events.
Robot-assisted laparoscopic prostatectomy (RALP) showed lower prostate cancer-specific mortality (2.0%) compared to open surgery (4.5%) after 12 years.
Prolonged operating time and extensive bleeding were key adverse event categories linked to worse oncological outcomes.
Preoperative factors were analyzed to identify patients at higher risk for intraoperative adverse events, aiding surgical planning.
Clinical Implications
Surgeons should be aware that intraoperative complications during radical prostatectomy may negatively impact long-term cancer control and survival. Minimizing adverse events, potentially through the use of robot-assisted techniques and careful patient selection, could improve oncological outcomes. Monitoring and managing operative time and bleeding are important to reduce risks.
Conclusion
Intraoperative adverse events during radical prostatectomy are significant predictors of cancer recurrence and mortality. The findings support the continued evaluation of surgical techniques and perioperative management to optimize long-term outcomes for prostate cancer patients.
References
LAPPRO Trial Investigators 2023 -- Complications Associated with Radical Prostatectomy and Their Links to Recurrence and Mortality
